Sewoon Medical Co., Ltd

KOSDAQ:A100700 Stock Report

Market Cap: ₩117.1b

Sewoon Medical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sewoon Medical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth33.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Does Sewoon Medical (KOSDAQ:100700) Deserve A Spot On Your Watchlist?

May 13
Does Sewoon Medical (KOSDAQ:100700) Deserve A Spot On Your Watchlist?

Is Sewoon Medical (KOSDAQ:100700) Likely To Turn Things Around?

Mar 08
Is Sewoon Medical (KOSDAQ:100700) Likely To Turn Things Around?

How Does Sewoon Medical Co., Ltd (KOSDAQ:100700) Stand Up To These Simple Dividend Safety Checks?

Feb 18
How Does Sewoon Medical Co., Ltd (KOSDAQ:100700) Stand Up To These Simple Dividend Safety Checks?

What Type Of Shareholders Own The Most Number of Sewoon Medical Co., Ltd (KOSDAQ:100700) Shares?

Jan 31
What Type Of Shareholders Own The Most Number of Sewoon Medical Co., Ltd (KOSDAQ:100700) Shares?

Sewoon Medical Co., Ltd's (KOSDAQ:100700) Stock Is Going Strong: Have Financials A Role To Play?

Jan 12
Sewoon Medical Co., Ltd's (KOSDAQ:100700) Stock Is Going Strong: Have Financials A Role To Play?

Sewoon Medical (KOSDAQ:100700) Shareholders Have Enjoyed A 93% Share Price Gain

Dec 24
Sewoon Medical (KOSDAQ:100700) Shareholders Have Enjoyed A 93% Share Price Gain

Will Sewoon Medical (KOSDAQ:100700) Multiply In Value Going Forward?

Dec 06
Will Sewoon Medical (KOSDAQ:100700) Multiply In Value Going Forward?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sewoon Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A100700 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202464,87514,14515,14216,857N/A
3/31/202467,20514,84920,55622,410N/A
12/31/202368,24714,95721,12023,076N/A
9/30/202367,25114,23321,54623,065N/A
6/30/202364,69412,72217,83119,718N/A
3/31/202362,51211,77110,08812,089N/A
12/31/202260,11610,4067,1119,279N/A
9/30/202260,27210,7596,5239,410N/A
6/30/202261,11411,1529,87012,936N/A
3/31/202261,64911,33916,16919,019N/A
12/31/202162,57912,28218,97921,469N/A
9/30/202161,45210,70717,80421,011N/A
6/30/202160,66410,38517,96221,336N/A
3/31/202162,90810,17017,92221,190N/A
12/31/202063,72910,20915,76419,252N/A
9/30/202065,54010,97416,57518,615N/A
6/30/202066,59211,87012,08116,055N/A
3/31/202066,37914,4428,52113,541N/A
12/31/201966,86913,9737,52113,481N/A
9/30/201965,59917,7215,28312,413N/A
6/30/201964,42116,7027,29613,253N/A
3/31/201963,36814,0826,56612,893N/A
12/31/201863,12113,8087,02712,195N/A
9/30/201862,58710,7638,75613,299N/A
6/30/201863,35610,3975,80910,673N/A
3/31/201861,4479,556N/A9,769N/A
12/31/201761,2309,177N/A8,229N/A
9/30/201759,5747,809N/A7,412N/A
6/30/201758,0717,565N/A9,406N/A
3/31/201757,7578,694N/A6,833N/A
12/31/201656,6208,349N/A6,349N/A
9/30/201657,6199,052N/A3,472N/A
6/30/201656,5173,968N/A646N/A
3/31/201656,0583,321N/A2,630N/A
12/31/201555,8673,064N/A3,652N/A
9/30/201554,9441,345N/A6,186N/A
6/30/201555,0926,456N/A6,948N/A
3/31/201553,6475,162N/A8,637N/A
12/31/201452,8715,992N/A8,402N/A
9/30/201452,5898,145N/A7,769N/A
6/30/201452,1007,964N/A8,908N/A
3/31/201452,6049,192N/A8,087N/A
12/31/201351,4238,519N/A9,619N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A100700's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if A100700's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A100700's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A100700's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A100700's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A100700's Return on Equity is forecast to be high in 3 years time


Discover growth companies